Mid-trimester uterine artery Doppler for aspirin discontinuation in pregnancies at high risk for preterm pre-eclampsia: Post-hoc analysis of StopPRE trial.
Erika BonacinaPablo Garcia-ManauMonica LópezSara CaamiñaÀngels VivesEva Lopez-QuesadaMarta RicartAnna MarotoLaura de MingoElena PintadoLaura Castillo-RibellesLourdes MartínAlicia Rodriguez-ZuritaEsperanza GarciaMar PallarolsLaia Vidal-SagnierMireia TeixidorCarmen Orizales-LagoAdela Pérez-GomezVanesa OcañaLinda PuertoPilar MillánMercè AlsiusSonia DiazNerea MaizElena CarrerasAnna SuyManel MendozaPublished in: BJOG : an international journal of obstetrics and gynaecology (2023)
Discontinuing aspirin treatment at 24-28 weeks in women with a UtAPI ≤90th percentile was non-inferior to continuing aspirin treatment until 36 weeks for preventing preterm pre-eclampsia.